COG
Cambridge Cognition develops digital cognitive assessment technologies and tools for CNS clinical trials and healthcare research. The company offers an end-to-end platform including touchscreen cognitive assessments, voice analysis, electronic questionnaires, high-frequency testing, and decentralised clinical trial capabilities, used by pharmaceutical companies, research institutions, and clinicians worldwide. With over 30 years of scientific validation, its Cantab portfolio supports drug development, patient experience, and data management across multiple therapeutic areas. Headquartered in the United Kingdom, the organization focuses on neuroscience technology and cognitive assessment expertise for both academic research and clinical applications.
No recent news for this company.
No recent deals for this company.